1 Market Overview

1.1 Product Overview and Scope of NGS-Based Monitoring and Diagnostic Test

1.2 Classification of NGS-Based Monitoring and Diagnostic Test by Type

1.2.1 Overview: Global NGS-Based Monitoring and Diagnostic Test Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type in 2020

1.2.3 Commercial Assays/Tests

1.2.4 Laboratory Developed Tests

1.2.5 Direct to Consumer Test

1.2.6 Pre-Commercial Tests

1.3 Global NGS-Based Monitoring and Diagnostic Test Market by Application

1.3.1 Overview: Global NGS-Based Monitoring and Diagnostic Test Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Out-Patient Clinics/General Practitioners

1.3.3 Diagnostic Centers

1.3.4 Hospitals

1.3.5 Others

1.4 Global NGS-Based Monitoring and Diagnostic Test Market Size & Forecast

1.5 Global NGS-Based Monitoring and Diagnostic Test Market Size and Forecast by Region

1.5.1 Global NGS-Based Monitoring and Diagnostic Test Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global NGS-Based Monitoring and Diagnostic Test Market Size by Region, (2016-2021)

1.5.3 North America NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)

1.5.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)

1.5.6 South America NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 NGS-Based Monitoring and Diagnostic Test Market Drivers

1.6.2 NGS-Based Monitoring and Diagnostic Test Market Restraints

1.6.3 NGS-Based Monitoring and Diagnostic Test Trends Analysis

2 Company Profiles

2.1 Agilent Technologies, Inc.

2.1.1 Agilent Technologies, Inc. Details

2.1.2 Agilent Technologies, Inc. Major Business

2.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.1.4 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans

2.2 Ancestry.com LLC

2.2.1 Ancestry.com LLC Details

2.2.2 Ancestry.com LLC Major Business

2.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.2.4 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Ancestry.com LLC Recent Developments and Future Plans

2.3 ArcherDX, Inc.

2.3.1 ArcherDX, Inc. Details

2.3.2 ArcherDX, Inc. Major Business

2.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.3.4 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 ArcherDX, Inc. Recent Developments and Future Plans

2.4 Beijing Genomics Institute (BGI)

2.4.1 Beijing Genomics Institute (BGI) Details

2.4.2 Beijing Genomics Institute (BGI) Major Business

2.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.4.4 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Beijing Genomics Institute (BGI) Recent Developments and Future Plans

2.5 Cancer Genetics, Inc.

2.5.1 Cancer Genetics, Inc. Details

2.5.2 Cancer Genetics, Inc. Major Business

2.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.5.4 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Cancer Genetics, Inc. Recent Developments and Future Plans

2.6 CENTOGENE AG

2.6.1 CENTOGENE AG Details

2.6.2 CENTOGENE AG Major Business

2.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.6.4 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 CENTOGENE AG Recent Developments and Future Plans

2.7 F. Hoffmann-La Roche Ltd

2.7.1 F. Hoffmann-La Roche Ltd Details

2.7.2 F. Hoffmann-La Roche Ltd Major Business

2.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.7.4 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

2.8 GenePath Dx

2.8.1 GenePath Dx Details

2.8.2 GenePath Dx Major Business

2.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.8.4 GenePath Dx NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 GenePath Dx Recent Developments and Future Plans

2.9 Illumina, Inc.

2.9.1 Illumina, Inc. Details

2.9.2 Illumina, Inc. Major Business

2.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.9.4 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Illumina, Inc. Recent Developments and Future Plans

2.10 Laboratory Corporation of America Holdings

2.10.1 Laboratory Corporation of America Holdings Details

2.10.2 Laboratory Corporation of America Holdings Major Business

2.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.10.4 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans

2.11 Myriad Genetics, Inc.

2.11.1 Myriad Genetics, Inc. Details

2.11.2 Myriad Genetics, Inc. Major Business

2.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.11.4 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Myriad Genetics, Inc. Recent Developments and Future Plans

2.12 QIAGEN N.V.

2.12.1 QIAGEN N.V. Details

2.12.2 QIAGEN N.V. Major Business

2.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.12.4 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 QIAGEN N.V. Recent Developments and Future Plans

2.13 Quest Diagnostics Incorporated

2.13.1 Quest Diagnostics Incorporated Details

2.13.2 Quest Diagnostics Incorporated Major Business

2.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.13.4 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Quest Diagnostics Incorporated Recent Developments and Future Plans

2.14 Siemens Healthineers, Inc.

2.14.1 Siemens Healthineers, Inc. Details

2.14.2 Siemens Healthineers, Inc. Major Business

2.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.14.4 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Siemens Healthineers, Inc. Recent Developments and Future Plans

2.15 Thermo Fisher Scientific Inc.

2.15.1 Thermo Fisher Scientific Inc. Details

2.15.2 Thermo Fisher Scientific Inc. Major Business

2.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.15.4 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans

2.16 HTG Molecular Diagnostics, Inc.

2.16.1 HTG Molecular Diagnostics, Inc. Details

2.16.2 HTG Molecular Diagnostics, Inc. Major Business

2.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.16.4 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 HTG Molecular Diagnostics, Inc. Recent Developments and Future Plans

2.17 Vela Diagnostics Pte. Ltd.

2.17.1 Vela Diagnostics Pte. Ltd. Details

2.17.2 Vela Diagnostics Pte. Ltd. Major Business

2.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product and Solutions

2.17.4 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Vela Diagnostics Pte. Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global NGS-Based Monitoring and Diagnostic Test Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 NGS-Based Monitoring and Diagnostic Test Players Market Share

3.2.2 Top 10 NGS-Based Monitoring and Diagnostic Test Players Market Share

3.2.3 Market Competition Trend

3.3 NGS-Based Monitoring and Diagnostic Test Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global NGS-Based Monitoring and Diagnostic Test Revenue and Market Share by Type (2016-2021)

4.2 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application (2016-2021)

5.2 NGS-Based Monitoring and Diagnostic Test Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)

6.2 North America NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)

6.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country

6.3.1 North America NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2026)

6.3.2 United States NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

6.3.3 Canada NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

6.3.4 Mexico NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)

7.2 Europe NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)

7.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country

7.3.1 Europe NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2026)

7.3.2 Germany NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

7.3.3 France NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

7.3.4 United Kingdom NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

7.3.5 Russia NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

7.3.6 Italy NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)

8.2 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)

8.3 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region

8.3.1 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Region (2016-2026)

8.3.2 China NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

8.3.3 Japan NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

8.3.4 South Korea NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

8.3.5 India NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

8.3.7 Australia NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)

9.2 South America NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)

9.3 South America NGS-Based Monitoring and Diagnostic Test Market Size by Country

9.3.1 South America NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2026)

9.3.2 Brazil NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

9.3.3 Argentina NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)

10.2 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)

10.3 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country

10.3.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2026)

10.3.2 Turkey NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

10.3.4 UAE NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global NGS-Based Monitoring and Diagnostic Test Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global NGS-Based Monitoring and Diagnostic Test Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market NGS-Based Monitoring and Diagnostic Test Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) by Region (2016-2021)

Table 5. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Region (2021-2026)

Table 6. Agilent Technologies, Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Agilent Technologies, Inc. Major Business

Table 8. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 9. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Ancestry.com LLC Corporate Information, Head Office, and Major Competitors

Table 11. Ancestry.com LLC Major Business

Table 12. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 13. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. ArcherDX, Inc. Corporate Information, Head Office, and Major Competitors

Table 15. ArcherDX, Inc. Major Business

Table 16. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 17. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Beijing Genomics Institute (BGI) Corporate Information, Head Office, and Major Competitors

Table 19. Beijing Genomics Institute (BGI) Major Business

Table 20. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 21. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Cancer Genetics, Inc. Corporate Information, Head Office, and Major Competitors

Table 23. Cancer Genetics, Inc. Major Business

Table 24. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 25. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. CENTOGENE AG Corporate Information, Head Office, and Major Competitors

Table 27. CENTOGENE AG Major Business

Table 28. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 29. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors

Table 31. F. Hoffmann-La Roche Ltd Major Business

Table 32. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 33. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. GenePath Dx Corporate Information, Head Office, and Major Competitors

Table 35. GenePath Dx Major Business

Table 36. GenePath Dx NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 37. GenePath Dx NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Illumina, Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Illumina, Inc. Major Business

Table 40. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 41. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Laboratory Corporation of America Holdings Corporate Information, Head Office, and Major Competitors

Table 43. Laboratory Corporation of America Holdings Major Business

Table 44. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 45. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Myriad Genetics, Inc. Corporate Information, Head Office, and Major Competitors

Table 47. Myriad Genetics, Inc. Major Business

Table 48. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 49. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. QIAGEN N.V. Corporate Information, Head Office, and Major Competitors

Table 51. QIAGEN N.V. Major Business

Table 52. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 53. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Quest Diagnostics Incorporated Corporate Information, Head Office, and Major Competitors

Table 55. Quest Diagnostics Incorporated Major Business

Table 56. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 57. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Siemens Healthineers, Inc. Corporate Information, Head Office, and Major Competitors

Table 59. Siemens Healthineers, Inc. Major Business

Table 60. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 61. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Thermo Fisher Scientific Inc. Major Business

Table 64. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 65. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. HTG Molecular Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors

Table 67. HTG Molecular Diagnostics, Inc. Major Business

Table 68. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 69. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Vela Diagnostics Pte. Ltd. Corporate Information, Head Office, and Major Competitors

Table 71. Vela Diagnostics Pte. Ltd. Major Business

Table 72. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product and Solutions

Table 73. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) by Players (2019-2021)

Table 75. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Players (2019-2021)

Table 76. Breakdown of NGS-Based Monitoring and Diagnostic Test by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. NGS-Based Monitoring and Diagnostic Test Players Head Office, Products and Services Provided

Table 78. NGS-Based Monitoring and Diagnostic Test Mergers & Acquisitions in the Past Five Years

Table 79. NGS-Based Monitoring and Diagnostic Test New Entrants and Expansion Plans

Table 80. Global NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) by Type (2016-2021)

Table 81. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Type (2016-2021)

Table 82. Global NGS-Based Monitoring and Diagnostic Test Revenue Forecast by Type (2021-2026)

Table 83. Global NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2021)

Table 84. Global NGS-Based Monitoring and Diagnostic Test Revenue Forecast by Application (2021-2026)

Table 85. North America NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2021) & (USD Million)

Table 86. North America NGS-Based Monitoring and Diagnostic Test Revenue by Type (2021-2026) & (USD Million)

Table 87. North America NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2021) & (USD Million)

Table 88. North America NGS-Based Monitoring and Diagnostic Test Revenue by Application (2021-2026) & (USD Million)

Table 89. North America NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2021) & (USD Million)

Table 90. North America NGS-Based Monitoring and Diagnostic Test Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe NGS-Based Monitoring and Diagnostic Test Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe NGS-Based Monitoring and Diagnostic Test Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe NGS-Based Monitoring and Diagnostic Test Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Region (2021-2026) & (USD Million)

Table 103. South America NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2021) & (USD Million)

Table 104. South America NGS-Based Monitoring and Diagnostic Test Revenue by Type (2021-2026) & (USD Million)

Table 105. South America NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2021) & (USD Million)

Table 106. South America NGS-Based Monitoring and Diagnostic Test Revenue by Application (2021-2026) & (USD Million)

Table 107. South America NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2021) & (USD Million)

Table 108. South America NGS-Based Monitoring and Diagnostic Test Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. NGS-Based Monitoring and Diagnostic Test Picture

Figure 2. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type in 2020

Figure 3. Commercial Assays/Tests

Figure 4. Laboratory Developed Tests

Figure 5. Direct to Consumer Test

Figure 6. Pre-Commercial Tests

Figure 7. NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application in 2020

Figure 8. Out-Patient Clinics/General Practitioners Picture

Figure 9. Diagnostic Centers Picture

Figure 10. Hospitals Picture

Figure 11. Others Picture

Figure 12. Global NGS-Based Monitoring and Diagnostic Test Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global NGS-Based Monitoring and Diagnostic Test Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Region (2016-2026)

Figure 15. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Region in 2020

Figure 16. North America NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. NGS-Based Monitoring and Diagnostic Test Market Drivers

Figure 22. NGS-Based Monitoring and Diagnostic Test Market Restraints

Figure 23. NGS-Based Monitoring and Diagnostic Test Market Trends

Figure 24. Agilent Technologies, Inc. Recent Developments and Future Plans

Figure 25. Ancestry.com LLC Recent Developments and Future Plans

Figure 26. ArcherDX, Inc. Recent Developments and Future Plans

Figure 27. Beijing Genomics Institute (BGI) Recent Developments and Future Plans

Figure 28. Cancer Genetics, Inc. Recent Developments and Future Plans

Figure 29. CENTOGENE AG Recent Developments and Future Plans

Figure 30. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

Figure 31. GenePath Dx Recent Developments and Future Plans

Figure 32. Illumina, Inc. Recent Developments and Future Plans

Figure 33. Laboratory Corporation of America Holdings Recent Developments and Future Plans

Figure 34. Myriad Genetics, Inc. Recent Developments and Future Plans

Figure 35. QIAGEN N.V. Recent Developments and Future Plans

Figure 36. Quest Diagnostics Incorporated Recent Developments and Future Plans

Figure 37. Siemens Healthineers, Inc. Recent Developments and Future Plans

Figure 38. Thermo Fisher Scientific Inc. Recent Developments and Future Plans

Figure 39. HTG Molecular Diagnostics, Inc. Recent Developments and Future Plans

Figure 40. Vela Diagnostics Pte. Ltd. Recent Developments and Future Plans

Figure 41. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Players in 2020

Figure 42. NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 43. Global Top 3 Players NGS-Based Monitoring and Diagnostic Test Revenue Market Share in 2020

Figure 44. Global Top 10 Players NGS-Based Monitoring and Diagnostic Test Revenue Market Share in 2020

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 46. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Type in 2020

Figure 47. Global NGS-Based Monitoring and Diagnostic Test Market Share Forecast by Type (2021-2026)

Figure 48. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Application in 2020

Figure 49. Global NGS-Based Monitoring and Diagnostic Test Market Share Forecast by Application (2021-2026)

Figure 50. North America NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2016-2026)

Figure 51. North America NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2016-2026)

Figure 52. North America NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Country (2016-2026)

Figure 53. United States NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Canada NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Mexico NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Europe NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2016-2026)

Figure 57. Europe NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2016-2026)

Figure 58. Europe NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Country (2016-2026)

Figure 59. Germany NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. France NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. United Kingdom NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Russia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Italy NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2016-2026)

Figure 65. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Region (2016-2026)

Figure 67. China NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Japan NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South Korea NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. India NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Southeast Asia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Australia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South America NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2016-2026)

Figure 74. South America NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2016-2026)

Figure 75. South America NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Country (2016-2026)

Figure 76. Brazil NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Argentina NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2016-2026)

Figure 79. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2016-2026)

Figure 80. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Country (2016-2026)

Figure 81. Turkey NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. UAE NGS-Based Monitoring and Diagnostic Test Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source